Daily Health News Issue # 484 for 4/28/2026
- The NY Times piece on health insurance costs has a video of a person caught in the ACA squeeze, whose premiums went up almost ten fold.
- Health Insurers:
- Are promising to lower the "administrative burden" of prior authorizations – but finding data on insurer performance is hard to track down.
- Lowering CEO pay due to rough 2025.
- Interesting piece on how GLP-1 drugs lower 'food noise' – (and one reason that if you go back off GLP-1, the 'noise' – and weight – come back).
See you tomorrow.
See our "top articles" list below. For a synoposis of all 36 articles curated today, see further below, and to see each of these articles listed with short summary just click here.
Click here to keep those cards and letters coming… including if you want to – gasp! – unsubscribe (please don't!)
Audio/Video
Today's Quote:
"The adoption of artificial intelligence (AI)-powered tools is accelerating rapidly across all layers of healthcare systems,"
… Nature Medicine editorial 2026.
Today's Top Articles
Of the 36 articles curated today, here are the top 6 in our judgment:
| Article_Title | Article_Takeaway |
|---|---|
| Skyrocketing Health Insurance Forces Americans to Scramble for Care | As federal health care credits lapse, some older Americans face unaffordable premiums and delays in getting needed care. |
| The Prior Authorization Data Is Public. Good Luck Finding It. | Public prior-authorization data exists, but it is fragmented and hard to find, making real transparency and patient-level comparisons nearly impossible. |
| Health plans advance pledge with standardized electronic prior auth commitment | About 50 insurers pledged to standardize electronic prior authorization for most medical services, aiming to speed decisions and reduce provider friction. |
| Health insurer CEO pay stagnated as profits faltered in 2025 | Health insurer CEO pay barely changed in 2025 as profits weakened, while UnitedHealth’s Stephen Hemsley remained the top-paid executive and security spending mostly fell. |
| The Day the Food Noise Died | GLP-1 obesity drugs appear to quiet relentless food thoughts, prompting researchers to explore how set points and appetite signals may shape obesity. |
| Pregnancy With Lupus Is Risky. Would She Be Able to Carry Her Baby to Term? | A woman with severe lupus and kidney disease carried a pregnancy through dialysis and later got a kidney transplant, despite major risks to her and her baby. |
Today's Graphic
GLP-1 Persistence Rates for Weight Loss (Source: Medscape and the Journal of Managed Care and Specialty Pharmacy, March 2026). See below or click here

Today's Digest
Here is a summary of all 36 articles curated today into the Competitive Research Analytics Platform for 4/28/2026:
Today's Quote… "The adoption of artificial intelligence (AI)-powered tools is accelerating rapidly across all layers of healthcare systems," – Nature Medicine editorial 2026.
And now our summary …
CRAP's latest intake spans a notably broad arc of healthcare industry dynamics, with systemic financial pressure, access erosion, and technological transformation as persistent undercurrents. Federal Medicaid vulnerability commands significant attention: South Dakota projects over 1,200 enrollees could lose coverage under proposed work requirements, Ohio mental health providers are reeling from CareSource payment clawbacks, and Americans broadly fear impending cuts as the Trump administration advances Medicaid restrictions.
The expiration of federal premium subsidies is simultaneously squeezing older Americans out of commercial coverage. Long-term acute care hospitals are closing at an accelerating pace, worsening Medicare bed shortages and inflaming the site-neutral reimbursement debate.
On the payer side, Centene continues its bearish market trajectory, and health insurer CEO compensation held largely flat amid weakened profits. Prior authorization reform offered one of the cycle's more constructive signals, with approximately 50 insurers committing to a standardized electronic framework aimed at reducing provider friction.
Technology and clinical innovation generated substantial content: Intellia's CRISPR therapy posted strong Phase 3 results for hereditary angioedema; GLP-1 drugs are prompting researchers to revisit appetite set-point science; Trump's executive order signals openness to psychedelic-assisted therapies; and clinician-facing AI tools are converging rapidly, making trust and evidence grounding the new competitive differentiators.
Rural health fund disbursements are flowing disproportionately toward vendors rather than frontline clinics. A Nevada Medicaid fraud indictment, MAHA activism at the Supreme Court over glyphosate labeling, and a CareFirst-Thatch ICHRA partnership round out a dense and consequential briefing cycle.
See back issues of Daily C.R.A.P. on our website right here in the archive.
As of today, C.R.A.P. now has 207 subscribers
Want to drop us a line? E-Mail Us
Click here for ALL articles added to C.R.A.P. in the past 24 hours